Form D · Biotechnology
Tenex Health, Inc.
Rochester, MN · CIK 0001486594
Offering snapshot reported Mar 6, 2013 · SEC filing
- Reported sold
- $0 Offering amount: $30M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 20, 2013 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 6, 2013 | Amendment | $0 | $0vs Feb 26, 2013 | 0 | SEC filing |
| Feb 26, 2013 | Initial | $0 | No comparison | 0 | SEC filing |
| Jan 25, 2012 | Amendment | $11,843,224 | No comparison | 190 | SEC filing |
| Nov 16, 2011 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 24, 2011 | Initial | $4,600,000 | No comparison | 30 | SEC filing |
| May 27, 2010 | Amendment | $1,675,000 | $400,000vs Mar 12, 2010 | 26 | SEC filing |
| Mar 12, 2010 | Initial | $1,275,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.7M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-192375
Securities proceeds are being held in escrow pending one or more closings and release.
Assumes full $30,000,000.00 capital raise. Selling Agent also to receive warrants to purchase 3 shares for each 50 shares sold in the offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Emergent Financial Group, Inc. | 37891 |
Source: Form D, filed Mar 6, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Darryl Barnes | Executive |
| Julie Flanery | Executive |
| Jagi Gill | Director, Executive |
| Ivan Mijatovic | Director |
| Bernard Morrey, M.D. | Executive |
| Rom Papadopoulos | Director, Executive |
| Rom Papodopolous | Director |
| Tate Parham | Executive |
| Jay Smith | Executive |
| Clay Wilemon | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Rochester, MN, 55906